Fig. 8. Effect of nor-BNI (administered intraplantarly) or naloxone methiodide (NLXM; administered subcutaneously) on the antiinflammatory action of (A ) FE 20065, (B ) FE 200666, and (C ) U-69,593. *Significant difference from antagonist-treated groups, P < 0.05, analysis of variance (Dunnett test). FCA = Freund complete adjuvant.